Home
About
The Themis Story
About Us
The Themis Group
Our Milestones
Certifications
From The CEO’s Desk
The Board
The Management Committees
Our Presence
Domestic
International
Business Partners
Our Products
Formulations
API
Products
APIs
Innovations
R&D Breakthroughs
Product In Pipeline
Our Inventions
Manufacturing
Plant Information
QA & RA
EHS Support
Media
Events
News & Announcement
Social Responsibility
Careers
Contact
Head Office
Manufacturing Facilities
Enter Search String
Investor Relations
Annual Report
Annual Return
Financial Results
Share Holding Pattern
Notice to Members
Audited Financials of the Subsidiaries
Policies and Codes
Unclaimed Dividend and Shares
Schemes
Investor News
Press Releases
CSR Approved Projects
Miscellaneous
KYC Forms
Draft AOA
Annual Secretarial Compliance Report
Earning Calls Transcripts
Postal Ballot
Smart ODR
Stock Update
Investor Service Contact
Stock Price:
BSE
|
NSE
Investor News
- 2024-25
View:
2024-25
2023-24
2022-23
2021-22
2020-21
2019-20
Intimation of change in Registrar and Share Transfer Agent (RTA) of the Company
Intimation of Closure of Trading for the quarter ending on 31st December, 2024
Scheme of Amalgamation
Outcome of Board Meeting held on 18.11.2024
TML Outcome of Board Meeting on 25.10.2024
Newspaper Publication of Un-Audited Standalone & Consolidated Financial Results for the Quarter and Half year ended 30th September, 2024
Intimation of Board Meeting scheduled on 25th October, 2024
Intimation of Closure of Trading for the quarter and half year ended 30th September, 2024
Outcome of the Board Meeting on 26.07.2024
Newspaper Publication of Un-audited Financial Results for the Quarter Ended 30.06.2024
Proceedings of the 54th Annual General Meeting
Disclosure under Regulation 30 of SEBI
Intimation of the Board Meeting of Themis Medicare Ltd. scheduled on 26th July, 2024
Home
Investor Relations
Investor News